These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 16283677)
1. Small molecular anti-cytokine agents. Wagner G; Laufer S Med Res Rev; 2006 Jan; 26(1):1-62. PubMed ID: 16283677 [TBL] [Abstract][Full Text] [Related]
2. New approaches to the treatment of inflammatory disorders small molecule inhibitors of p38 MAP kinase. Peifer C; Wagner G; Laufer S Curr Top Med Chem; 2006; 6(2):113-49. PubMed ID: 16454763 [TBL] [Abstract][Full Text] [Related]
3. Cytokine-suppressive anti-inflammatory drugs (CSAIDs) inhibit invasion and MMP-1 production of ovarian carcinoma cells. Denkert C; Koch I; Berger S; Köbel M; Siegert A; Hauptmann S Cancer Lett; 2003 May; 195(1):101-9. PubMed ID: 12767518 [TBL] [Abstract][Full Text] [Related]
4. p38 MAP kinase inhibitors as anti inflammatory agents. Amir M; Somakala K; Ali S Mini Rev Med Chem; 2013 Dec; 13(14):2082-96. PubMed ID: 24107108 [TBL] [Abstract][Full Text] [Related]
5. MKK3/6-p38 MAPK signaling is required for IL-1beta and TNF-alpha-induced RANKL expression in bone marrow stromal cells. Rossa C; Ehmann K; Liu M; Patil C; Kirkwood KL J Interferon Cytokine Res; 2006 Oct; 26(10):719-29. PubMed ID: 17032166 [TBL] [Abstract][Full Text] [Related]
6. Endothelin-1 stimulates proinflammatory cytokine expression in human periodontal ligament cells via mitogen-activated protein kinase pathway. Liang L; Yu J; Zhou W; Liu N; E LL; Wang DS; Liu H J Periodontol; 2014 Apr; 85(4):618-26. PubMed ID: 23701479 [TBL] [Abstract][Full Text] [Related]
7. p38 MAPK inhibition in nucleus pulposus cells: a potential target for treating intervertebral disc degeneration. Studer RK; Aboka AM; Gilbertson LG; Georgescu H; Sowa G; Vo N; Kang JD Spine (Phila Pa 1976); 2007 Dec; 32(25):2827-33. PubMed ID: 18246004 [TBL] [Abstract][Full Text] [Related]
8. Imidazole inhibitors of cytokine release: probing substituents in the 2 position. Laufer SA; Striegel HG; Wagner GK J Med Chem; 2002 Oct; 45(21):4695-705. PubMed ID: 12361396 [TBL] [Abstract][Full Text] [Related]
9. Strong inhibition of TNF-alpha production and inhibition of IL-8 and COX-2 mRNA expression in monocyte-derived macrophages by RWJ 67657, a p38 mitogen-activated protein kinase (MAPK) inhibitor. Westra J; Doornbos-van der Meer B; de Boer P; van Leeuwen MA; van Rijswijk MH; Limburg PC Arthritis Res Ther; 2004; 6(4):R384-92. PubMed ID: 15225374 [TBL] [Abstract][Full Text] [Related]
10. Endotoxin recognition in fish results in inflammatory cytokine secretion not gene expression. Roher N; Callol A; Planas JV; Goetz FW; MacKenzie SA Innate Immun; 2011 Feb; 17(1):16-28. PubMed ID: 20083499 [TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-α and interleukin-1β expression pathway induced by Streptococcus mutans in macrophage cell line RAW 264.7. Kim JS; Kim KD; Na HS; Jeong SY; Park HR; Kim S; Chung J Mol Oral Microbiol; 2012 Jun; 27(3):149-59. PubMed ID: 22520385 [TBL] [Abstract][Full Text] [Related]
12. Inhibitors of TACE and Caspase-1 as anti-inflammatory drugs. Le GT; Abbenante G Curr Med Chem; 2005; 12(25):2963-77. PubMed ID: 16378499 [TBL] [Abstract][Full Text] [Related]
13. An in-vitro screening assay for the detection of inhibitors of proinflammatory cytokine synthesis: a useful tool for the development of new antiarthritic and disease modifying drugs. Laufer S; Greim C; Bertsche T Osteoarthritis Cartilage; 2002 Dec; 10(12):961-7. PubMed ID: 12464556 [TBL] [Abstract][Full Text] [Related]
14. Differential effect of p38 and MK2 kinase inhibitors on the inflammatory and toxicity biomarkers in vitro. Singh RK; Diwan M; Dastidar SG; Najmi AK Hum Exp Toxicol; 2018 May; 37(5):521-531. PubMed ID: 28629242 [TBL] [Abstract][Full Text] [Related]
15. Novel inhibitor of p38 MAP kinase as an anti-TNF-alpha drug: discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a potent and orally active anti-rheumatoid arthritis agent. Miwatashi S; Arikawa Y; Kotani E; Miyamoto M; Naruo K; Kimura H; Tanaka T; Asahi S; Ohkawa S J Med Chem; 2005 Sep; 48(19):5966-79. PubMed ID: 16162000 [TBL] [Abstract][Full Text] [Related]
16. Blockade of tumor necrosis factor-α converting enzyme (TACE) enhances IL-1β and IFN-γ via caspase-1 activation: a probable cause for loss of efficacy of TACE inhibitors in humans? Sharma M; Mohapatra J; Acharya A; Deshpande SS; Chatterjee A; Jain MR Eur J Pharmacol; 2013 Feb; 701(1-3):106-13. PubMed ID: 23266381 [TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effect and selectivity profile of AS1940477, a novel and potent p38 mitogen-activated protein kinase inhibitor. Terajima M; Inoue T; Magari K; Yamazaki H; Higashi Y; Mizuhara H Eur J Pharmacol; 2013 Jan; 698(1-3):455-62. PubMed ID: 23183108 [TBL] [Abstract][Full Text] [Related]
18. Tetrasubstituted imidazole inhibitors of cytokine release: probing substituents in the N-1 position. Laufer SA; Zimmermann W; Ruff KJ J Med Chem; 2004 Dec; 47(25):6311-25. PubMed ID: 15566301 [TBL] [Abstract][Full Text] [Related]
19. P38 MAPK mediates myocardial proinflammatory cytokine production and endotoxin-induced contractile suppression. Wang M; Sankula R; Tsai BM; Meldrum KK; Turrentine M; March KL; Brown JW; Dinarello CA; Meldrum DR Shock; 2004 Feb; 21(2):170-4. PubMed ID: 14752292 [TBL] [Abstract][Full Text] [Related]
20. Lidocaine attenuates proinflammatory cytokine production induced by extracellular adenosine triphosphate in cultured rat microglia. Su D; Gu Y; Wang Z; Wang X Anesth Analg; 2010 Sep; 111(3):768-74. PubMed ID: 20686009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]